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Introduction: The electromagnetic interference (EMI) of active implantable medical
devices (AIMDs) due to 125–135 kHz and HF (13.56MHz) radio-frequency identiﬁcation
(RFID) reader/writers are discussed based on in vitro experiments. The purpose of this paper
is to clarify the detailed EMI occurrence conditions of both implantable cardiac pacemakers
and implantable cardioverter deﬁbrillators (ICDs) when used in proximity to commercial low-
band RFID reader/writers.
Methods and results: A total of 20 types of pacemakers and 7 types of ICDs from 9
manufacturers are used in the experiments. The tested RFID reader/writers are 4 types of
125–135 kHz antennas and 26 types of HF antennas. The test system is newly constructed
based on the one previously proposed for the estimation of EMI due to mobile phones. The
measured reactions are missing of pacing pulses and generation of asynchronous pulses for
pacemaker functions and inappropriate tachyarrhythmia detection and delivery of therapy for
ICDs. In addition, measured EMI characteristics strongly depend on intermittent period of
RFID signals. However, all AIMDs tested return to normal operation once removed from
RFID exposure.
Conclusion: The detailed EMI characteristics of AIMDs and low-band RFID reader/
writers are obtained to prevent adverse interactions.
(J Arrhythmia 2009; 25: 142–152)
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Introduction
With increasing demand for wireless connectivity
and mobility support, various kinds of new wireless
communication devices such as mobile phones,
wireless local area networks, radio-frequency iden-
tiﬁcation (RFID) and electric article surveillance
(EAS) systems have been developed and used to
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transfer information from one place to another. RFID
technology supports non-contact automatic recogni-
tion along with fast data reading, multi-target
recognition and invisible recognition.1) As a key
enabler of supply chain management and near-ﬁeld
communication, RFID systems improve operation
eﬃciency when they are employed for logistics,
manufacturing, and public utilities. However, they
are wireless devices and so emit electromagnetic
ﬁelds (EMF) that could potentially cause electro-
magnetic interference (EMI) in other electronic
devices. EMI exposure to active implantable medical
devices (AIMDs) due to the prevalence of wireless
communication devices has become a very contro-
versial issue in recent years.2–15) This is because the
number of AIMD users has increased every year due
to technological advances in AIMDs and the aging
of the population. In Japan, shipments of implant-
able-cardiac pacemakers and implantable-cardiovert-
er deﬁbrillators (ICDs) rapidly increased from
29,800 devices in ﬁscal 1996 to 57,000 devices in
ﬁscal 2007. New wireless communication devices
as typiﬁed by RFID systems are being used every-
where. The EMI emitted by these devices should be
investigated to ensure a safe environment.
Regarding EMI eﬀects on AIMDs, including
pacemakers and ICDs, both in vitro and in vivo
research have been conducted. In particular, the
interference caused by mobile phone systems is
being investigated on a massive scale. Work includes
the eﬀect of ﬁrst-generation analog, and second-
generation2,4–6) and third-generation7) mobile
phones, as well as EMI from cellular base-stations.8)
Based on the results obtained, some EMI prevention
guidelines, which deﬁne the minimum safe distance,
have been published.9,10) Other EMI sources such
as electronic security systems,11) induction cooking
surfaces,3) and electromagnetic stimulation12) have
also been investigated. Concerning the EMI due to
RFID, the Ministry of Internal Aﬀairs and Commu-
nications of Japan reported research results to
determine the guidelines to prevent the EMI. On
the other hand, we have carried out in vitro experi-
ments to investigate the conditions under which EMI
occurs.13,14) Another study concerns EMI on AIMDs
due to RFID reader/writer signals.15)
Since the waveform and the periodicity of the
EMF strongly inﬂuence EMI characteristics, experi-
ments based on actual devices are required. The
purpose of this paper is to clarify the typical AIMD
EMI characteristics of low-band RFID reader/writ-
ers in more detail. In addition, the transmitting signal
conditions that trigger EMI are investigated to
prevent adverse interactions.
Methods
AIMDs and RFID reader/writers used in the
experiments
The AIMDs of 9 manufacturers, which included
20 pacemakers and 7 ICDs, were tested. The devices
included both single-chamber and dual-chamber
AIMDs (Table 1). These devices were typical of the
AIMDs from their manufacturers and were provided
by the Pacemaker Committee of Japan.
The commercial low-band RFID reader/writers
tested were 4 types with 125–135 kHz antennas and
26 types with HF (13.56MHz) antennas from 9
manufacturers (Table 2). The RFID systems were
classiﬁed according to their usage and antenna
shape. The stationary-type employs a ﬁxed antenna
that is usually located on surfaces such as a wall or
a desk. The handheld-type has a small antenna to
permit its use in mobile RFID terminals. The gate-
Table 1 The implantable-cardiac pacemakers and the implantable-cardioverter deﬁbrillator
used in the experiments. They are classiﬁed by the period marketed in Japan.
Model (quantity)
Period marketed Implantable cardiac Implantable cardioverter-
in Japan
pacemakers deﬁbrillators Total
SSI DDD ICD ICD(Single chamber) (Dual chamber)
Old
2 0 0 0 2(1995 and before)
Medium
1 1 0 0 2(1996 to 1998)
Recent 8 8 2 5 23(1999 and later)
Total 11 9 2 5 27
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type is a large antenna consisting of more than one
standing gate. Typical characteristics of the RFID
reader/writers tested are shown in Table 3. At the
normal operation mode, the 26 types of HF antennas
tested emit either continuous wave (CW) or inter-
mittent signals. The period varies from 20ms to
350ms depending on the antenna. Furthermore, to
investigate the eﬀects of intermittent period of
transmitting signal, 3 types of 125–135 kHz RFID
reader/writers were modiﬁed to emit signals with an
intermittent period of 2.05ms to 2.08 s.
Test conﬁguration
The in vitro EMI experiments were carried
out using a newly-developed measurement system
(Figure 1). This test system was based on the one
previously proposed for the estimation of EMI
emitted by mobile phones.9,16) The test system
consisted of a ﬂat human torso phantom, an ECG
signal generator, a chart recorder, an oscilloscope, a
measurement platform and a RFID reader/writer
antenna. The RFID reader/writer antenna was con-
nected to the controller or computer, and was
programmed to provide actual operating mode. The
ECG generator, to which are connected a resistor
(>2 k), supplied simulated cardiac pulses to the
AIMD through the atrial or ventricle electrode. In
addition, the simulated cardiac pulse and output
pulse of the AIMD was recorded and monitored by
using a chart recorder and an oscilloscope.
The experiments were conducted in a closed,
electromagnetically shielded anechoic chamber in
Hokkaido University. The human torso phantom
used in this experiment was developed based upon
Irnich’s model.17–19) Figure 2 gives the dimensions
of the human torso phantom. Both the atrial and
ventricular electrodes were modiﬁed to enable us to
isolate each chambers’ ECG signal level by more
than 20 dB.19) The tank of the phantom consisted of
an acrylic material and was ﬁlled with a saline
solution (NaCl 1.8 g/L). In the low frequency band,
most ECG components were low frequency and the
saline solution provided the same electric conduc-
tivity, 0.2 S/m, as the human body.20) In addition, the
relative dielectric constant and the conductivity of
the saline solution at 125–135 kHz to HF were 87
and 0.3 S/m, respectively.21) These values were set
to closely match those of human bodies.
Test procedures
To measure the EMI, we conducted ‘‘inhibition
tests’’ and ‘‘asynchronous tests’’. The inhibition test
examined missing pacing pulses generated by the
AIMD. There was no injection of the simulated pulse
in inhibition tests. An example of an inhibition test
result is shown in Figure 3(a). The required pacing
pulse was inhibited due to EMI. The asynchronous
test examined the generation of ﬁxed-rate asynchro-
nous pulses. Simulated cardiac pulses were injected
in asynchronous tests. An example of an asynchro-
nous test result is shown in Figure 3(b). When there is
no EMI, the AIMD senses the simulated pulse and
the pacing pulse is inhibited. However, an asynchro-
nous pulse was generated when the AIMD was
exposed to noise and switched to noise reversion
mode.
Table 2 The commercial low-band RFID reader/writers used in the experiments.
Type Frequency
125–135kHz HF (13.56 MHz)
Stationary 4 11
Handheld 0 13
Gate 0 2
Total 4 26
Table 3 Typical characteristics of tested low-band RFID reader/writers.
Characteristics Frequency
125–135kHz HF (13.56 MHz)
Speciﬁcation ISO/IEC 18000-2 ISO/IEC 18000-3
ISO/IEC 15693
Maximum 20 cm 60 cm
communication distance
Modulation Amplitude shift keying Amplitude shift keying
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Moreover, inappropriate tachyarrhythmia detec-
tion and delivery of therapy or shock were also
investigated in the experiments for ICDs. To obtain
conservative EMI estimation results, sensitivity
and refractory period were set at maximum (most
sensitive) and minimum, respectively. In addition,
the heart rate was set to 60 ppm and stimulation
mode was programmed to AAI or VVI. The sensing
and pacing polarity were either set to unipolar or
bipolar mode. As shown in Figure 4, the procedure
used depended on the antenna type. The antenna
positions were those described in a report by the
Ministry of Internal Aﬀairs and Communications
(MIC).22,23) The common points for all antennas
were as follows:
1) First, both sensitivity and refractory period
of pacemakers and ICDs were programmed to the
maximum sensitivity and the minimum time, re-
spectively.
2) The ECG signal for each mode was recorded
for 100 seconds. The distance between antennas and
the human torso phantom was increased when
interference occurred. In this case, the maximum
interference distance (distance at which EMI dis-
appears) was determined and recorded in centime-
ters.
3) The sensitivity of pacemakers and ICDs was
stepped down in ﬁve levels (maximum, 1.0mV,
2.4mV, 5.6mV, and minimum) and the maximum
interference distance was recorded.
RFID reader/writer
antenna
Distance
Human torso phantom
Pacemaker or ICD
Electrodes
Lead wire
Saline solution
(1.8 g/L)> 2 kΩ
RFID controller or
Computer
ECG signal generator
Function generator
Chart recorder
NEC San-ei RT3608
Oscilloscope
YOKOGAWA DL9240L
(a)
(b)
Figure 1 (a) The conﬁg-
uration and (b) overall view
of the test system used for
investigating active im-
plantable medical device
EMI caused by RFID read-
er/writers.
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4) Experiments were carried out for all combina-
tions of antennas and AIMDs. The operating modes
of pacemakers and ICDs included unipolar and
bipolar AAI and VVI modes.
In addition, the diﬀerence in procedure between
the antenna types was as follows:
Process 1 for the handheld-type and stationary-
type antenna: The human torso phantom was set
parallel to the antenna. The antenna was then moved
from side to side on the y axis (see Figure 1) while
doing the experiments. The maximum interference
distance was measured from the surface of the
antenna to the human torso phantom.
Process 1 for the gate-type antenna: The human
torso phantom was located on the perpendicular
bisector of the line between the two gate antennas,
as shown in Figure 5(a). Distance D was changed to
determine the maximum interference distance. This
distance was the spacing between the center of the
antenna (width direction) and the center of the
human torso phantom (depth direction).
Process 2 for the gate-type antenna: If distance D
in test process 1 reached 0 cm, test process 2 was
started. The human torso phantom was located on the
center of the line between the two gate antennas, as
shown in Figure 5(b). In addition, the phantom was
also located on the center of the antenna’s width.
Distance L was then changed, in one-centimeter
increments, to determine the maximum interference
distance. For each distance L, the angle of the human
body phantom  was changed by 45 degrees.
Distance L was the spacing between the antenna’s
surface and the center of human torso phantom
(depth direction).
Process 3 for the gate-type antenna: If distance
L in test process 2 reached 20 cm, test process 3 was
started. The human torso phantom was located
on the center of the antenna’s width as shown in
Figure 5(c). Distance L was then changed to deter-
mine the maximum interference distance. Distance
L was deﬁned in the same manner as in test
process 2.
360
30
30°
75°
360
Lead wires
Atria electrodeVentricular electrode
Saline solution
(1.8 g/L)
Pacemaker or ICD
Lead wires
Acrylic tank
10
25
(a) (b)
340 Figure 2 The human torso phantom used
in the experiments. The dimensions of (a)
side view and (b) front view. (all dimensions
in millimeters)
Inhibition of pacing pulses
(a)
Asynchronous pacing pulses
(b)
Figure 3 An example of the (a) inhibition and (b) asyn-
chronous test results.
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Results
The in vitro EMI experiments were conducted
using the test procedure described above. The results
of the experiments, which were obtained under two
diﬀerent conditions, are discussed. First, the test
results obtained by the combination of 27 types of
AIMDs and 30 types of RFID reader/writers are
discussed. The purpose of this experiment is to
clarify the typical EMI characteristics of actual low-
band RFID reader/writers and AIMDs. All RFID
reader/writers are operated in the normal operation
mode. Second, to investigate the detailed EMI
occurrence conditions depends on the intermittent
period of RFID signals, the test results obtained by
using modiﬁed 125–135 kHz RFID reader/writers
are discussed. The combination of 3 types of
pacemakers and 3 types of RFID reader/writers
were used for the test.
RFID reader/writers with normal operation mode
All 125–135 kHz RFID reader/writers tested were
the stationary-type. Total test mode number for
pacemaker function was 638, the combination of 4
antennas, and AIMD operation modes (Figure 4). The
test results for the inhibition and asynchronous test at
diﬀerent AIMD sensitivities are shown in Figure 6. In
this section, the ﬁgures include the results of both
unipolar and bipolar sensing/pacing mode. From
these results, at the maximum sensitivity the total
aﬀected mode number and aﬀected ratio were 194
and 30.4%, respectively. The maximum interference
distance in the inhibition test was 16 cm for pace-
makers and 15 cm for ICDs. In addition, the
maximum interference distance in the asynchronous
test was 17 cm for pacemakers and 4 cm for ICDs.
At the maximum sensitivity, the largest eﬀect on
pacemaker function was both the missing of a pacing
pulse and generation of asynchronous pulse for more
than 2 seconds (including complete inhibition and
continuous generation of asynchronous pulses). As
for the deﬁbrillation function, when the antenna and
the human torso phantom were in close proximity, an
inappropriate tachyarrhythmia was detected and
deﬁbrillation shock was delivered by one ICD. This
deﬁbrillation shock was generated only when they
Start
Set pacemaker or ICD parameters.
Sensitivity: maximum, Refractory: minimum
Operating mode: AAI or VVI, Polarity: Unipolar or bipolar
Stationary-type and handheld-type
RFID reader/writer antenna
Gate-type
RFID reader/writer antenna
Inhibition and asynchronous test
Process 1: The human torso phantom is
parallel to the antenna.
Inhibition and asynchronous test
Process 1: The human torso model is
perpendicular to the antenna and 
outside of the gate.
Process 2: The human torso model is inside
of the gate and direction is changed.
Process 3: The human torso model is parallel
to the antenna and inside of the gate.
Recode ECG signal and measure maximum interference distance
Check the inappropriate tachyarrhythmia detection for ICD
Step down sensitivity to five levels:
Maximum, 1.0 mV, 2.4 mV, 5.6 mV, minimum
EMI occurs? Yes
No Change operating mode or polarity
End Complete test with respect to all conditions
Figure 4 The procedure of the experiments.
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were in close proximity and the ICD was set at
maximum sensitivity. The EMI was rapidly sup-
pressed when the sensitivity was reduced.
For the HF stationary-type antennas, the total test
mode number for pacemaker function was 814. The
test results for the inhibition and asynchronous test
are shown in Figure 7(a). These results show that the
total aﬀected mode number and aﬀected ratio were
19 and 2.3%, respectively, at maximum sensitivity.
All ICDs were not aﬀected by the HF stationary type
antennas. In addition, the maximum interference
distances of the pacemakers are 15 cm in the
inhibition tests and 2 cm in the asynchronous tests.
The largest eﬀect on pacemaker operation followed
those found in the 125–135 kHz stationary-type
antenna tests described above.
Next, for the HF handheld-type antenna, the total
test mode number for pacemaker function was 1,021.
The test results for the inhibition and asynchronous
test are shown in Figure 7(b). These results show that
the total aﬀected mode number and aﬀected ratio
were 8 and 0.8%, respectively, at maximum sensi-
tivity. The EMI was observed only in inhibition tests
for pacemakers. The maximum interference distance
was 3 cm. The largest eﬀect on pacemaker operation
was the missing of pacing pulse for more than 2
seconds.
For the HF gate-type antenna, the total test mode
number for pacemaker function was 438. The test
results for the inhibition and asynchronous test are
shown in Figure 7(c). From these results, at maximum
sensitivity, the total aﬀected mode number and
aﬀected ratio were 14 and 3.2%, respectively.
During test process 1, no EMI was observed. The
aﬀected modes in test process 2 and test process 3
were 1 and 13, respectively. The maximum interfer-
ence distance in the inhibition tests was 15 cm for
pacemakers and 4 cm for ICDs. In addition, the
maximum interference distance in the asynchronous
tests was 23 cm for pacemakers. The ICDs were not
aﬀected in the asynchronous tests. The largest eﬀect
on pacemaker operation was both the missing of
pacing pulse and the generation of asynchronous
pulses for more than 2 seconds. In addition,
deﬁbrillation shock was generated for distances of
less than 3 cm. This deﬁbrillation shock was not
observed when the sensitivity was reduced.
RFID reader/writers with modiﬁed intermittent
period
The transmitting signals used in the experiments
described in the previous section were either CW or
intermittent with periods from 20ms to 350ms
depending on the antenna. In addition, the signals
had diﬀerent duty ratios. To quantitatively evaluate
the eﬀects of the intermittent period of the trans-
mitting signal, additional investigations were carried
out. The 3 stationary-type 125–135 kHz antennas
that frequently aﬀected AIMD operation were
modiﬁed to change the intermittent period of trans-
mitting signal and used in subsequent experiments.
The AIMDs tested were the 3 pacemakers that
exhibited some operation impairment in the experi-
ments described in the previous section. The trans-
Gate-type antennas
Distance: D Human torso phantom
Phantom platform
(a)
(b)
(c)Distance: L
Gate-type antennas
Distance: L
Gate-type antennas
Angle: θ
Figure 5 Top view of (a) process 1, (b) process 2 and
(c) process 3 for the gate-type antenna.
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mitting signals had a duty ratio of 50% and periods
of 2.05ms, 8.19ms, 16.3ms, 32.8ms, 65.5ms,
524ms, 1.05 s, and 2.08 s. The test procedure
followed that of the stationary-type antennas. In
addition, the sensitivity of pacemakers was ﬁxed to
the maximum value.
The results of the inhibition tests are shown in
Figure 8(a). At periods of 524ms and 1.05 s, the
aﬀected ratios exceeded 10%. Moreover, these
periods yielded the longest maximum interference
distances. This was because these periods matched
the physiological periods of human heartbeat. In this
case, the EMI detection function of the AIMDs
failed to work properly because of the diﬃculty of
diﬀerentiating the induced voltage due to EMI from
that created by the ECG signal. The results of the
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Figure 6 The results of the inhibition test
and asynchronous test for the 125–135 kHz
stationary-type antenna.
Figure 7 The results of the inhibition test
and asynchronous test for the HF (a) sta-
tionary-type antenna, (b) handheld-type an-
tenna and (c) gate-type antenna.
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asynchronous tests are shown in Figure 8(b). They
show high aﬀection rates (>8%) and long interfer-
ence distances, 16.3ms, 32.8ms and 65.5ms. These
periods lay in the most sensitive frequency range of
the AIMDs’ sensing circuit.
Discussion
From our experiments using the RFID reader/
writers with normal operation mode, we conﬁrmed
the following points. All interference eﬀects are
reversible and disappear when the antenna is
removed. In addition, no AIMD suﬀered a program
reset. Moreover, the inappropriate delivery of deﬁb-
rillation shock occurred only when the ICDs were set
at maximum sensitivity and were located very close
to and parallel to the antenna. Regarding the
maximum interference distance, obtained results
fundamentally agree with the previously reported
distance.22,23) For example, the maximum interfer-
ence distance of the stationary-type and handheld-
type antennas was less than 17 cm, which satisﬁed
the 22 cm guideline.10)
The RFID systems described in this paper are low-
band RFID reader/writers; they use 125–135 kHz or
HF.24–26) These RFID systems provide power to
passive tags via inductive coupling. Because of this,
the reader/writer antennas generate relatively strong
magnetic ﬁelds. The operating principle of tag
powering is as follows. When the alternating
magnetic ﬁeld, which is generated by the RFID
reader/writer antenna, passes through the antenna
coil of the tag, an induced voltage is produced. This
interaction follows Faraday’s law of induction. The
induced voltage Vi is
Vi ¼ N
dt
dt
ð1Þ
where t is the magnetic ﬂux through the area
perpendicular to the coil, and N is the number of
turns of the tag coil. t is a scalar product of
the magnetic ﬂux density ~B and the area of the tag
coil ~S.
t ¼ ~B  ~S ð2Þ
From equation (2), the highest electromotive force
is obtained when the tag coil is concentric with and
parallel to the coil of the RFID reader/writer
antenna. The induced voltage is rectiﬁed to DC
voltage and activates the tag’s function. However,
the EMI caused by low-band RFID reader/writers is
assumed to be caused by the alternating magnetic
ﬁeld from the antennas.11,14) In this case, it is
assumed that a ‘‘one turn coil’’ is connected between
the anode and cathode electrode of the AIMD, since
the tissues of the human body are electric conduc-
tors. The magnetic ﬂux density through the coil
generates an electromotive force between the elec-
trodes of the AIMD. If this electromotive force
exceeds the AIMD’s sensing threshold level, it is
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Figure 8 The results of the (a) inhibition
test and (b) asynchronous test, which are
carried out with diﬀerent transmitting signal
periods.
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diﬃcult to recognize correct ECG signals and may
malfunction.
In addition, when the transmitting signal has a
time-varying envelope, a low-frequency interference
signal is generated from the induced high frequency
signal.27) This is due to the nonlinear characteristics
of the AIMD’s sensing circuit. If the low frequency
interference signal so produced lies in the same
frequency band as the ECG signal (1Hz to more than
1 kHz), the EMI occurrence probability is much
higher.
Since the EMI caused by the low-band RFID
reader/writer antenna is triggered by the magnetic
ﬁeld, the angle between the human torso phantom
and the antenna also plays an important role in
EMI occurrence. As shown in test process 1 of the
gate-type antenna, if the human torso phantom is
located on the perpendicular bisector of the line
between the two antenna gates, no EMI is observed
in any of the AIMDs tested. These results conﬁrm
the validity of the published guideline by the
MIC.10) In the guideline, it is stated that ‘‘Where
gate-type RFID equipment is installed of where an
RFID sticker is posted, people with an AIMD
should walk in the middle of the pathway without
stopping’’.
From the experiments using the RFID reader/
writers with modiﬁed intermittent period, transmit-
ting signals with speciﬁc periods yield long max-
imum interference distances. The RFID reader/
writer antennas transmit intermittent signals for
anti-collision or multi-antenna function. Avoiding
the transmitting signal periods obtained by the
experiments (between 16.3ms to 1.05ms) can sup-
press pacing pulses and switching to noise reversion
mode.
Conclusion
The EMI characteristics of pacemakers and ICDs
due to low-band RFID reader/writers were discussed
based on the results of in vitro experiments. The
AIMDs examined were 20 types of pacemakers and
7 types of ICDs from 9 manufacturers. The com-
mercial RFID reader/writers tested were 4 types of
125–135 kHz antennas and 26 types of HF antennas;
the latter included stationary-type, handheld-type
and gate-type antennas.
The largest eﬀects were both complete missing of
pacing pulses and continuous generation of asyn-
chronous pulses. In addition, deﬁbrillation shock was
generated by few ICDs but only when they were
located very close (<3 cm) to the antenna, and were
set at maximum sensitivity. The eﬀects of trans-
mitting signal period were investigated using modi-
ﬁed 125–135 kHz antennas. High aﬀection rates rate
and long maximum interference distances were
observed for speciﬁc periods. If the RFID reader/
writers avoided these periods when emitting the
signal, the EMI was reduced or eliminated.
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